Differential Modulation of Rat Hepatic Stellate Phenotype by Natural and Synthetic Retinoids

Hepatology

Volumn 39, Issue 1, 2004, Pages 97-108

  Hellemans, Karine ^a,d   Verbuyst, Peggy ^a   Quartier, Erik ^a   Schuit, Frans ^a   Rombouts, Krista ^a   Chandraratna, Ross A S ^b   Schuppan, Detlef ^c   Geerts, Albert ^a,e  

^a DIABETES RESEARCH CENTER   (Belgium)

^b ALLERGAN INC   (United States)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d FREE UNIVERSITY OF BRUSSELS   (Belgium)

^e VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

4 [2 (5,5,8,8 TETRAMETHYL 5,6,7,8 TETRAHYDRO 2 NAPHTHALENYL) 1 PROPENYL]BENZOIC ACID; 4 [2 [5,6 DIHYDRO 5,5 DIMETHYL 8 (4 METHYLPHENYL) 2 NAPHTHYL]ETHYNYL]BENZOIC ACID; AGN 194204; ALITRETINOIN; BROXURIDINE; COLLAGEN TYPE 1; COLLAGEN TYPE 3; FIBRONECTIN; LIGAND; RECEPTOR PROTEIN; RECEPTOR SUBTYPE; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID; RETINOID X RECEPTOR; UNCLASSIFIED DRUG; 4 (2 (5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHALENYL) 1 PROPENYL)BENZOIC ACID; 4-(2-(5,6,7,8-TETRAHYDRO-5,5,8,8-TETRAMETHYL-2-NAPHTHALENYL)-1-PROPENYL)BENZOIC ACID; ANTINEOPLASTIC AGENT; BENZOIC ACID DERIVATIVE; MESSENGER RNA; SCLEROPROTEIN; TETRALIN DERIVATIVE; TRANSCRIPTION FACTOR; UNSATURATED FATTY ACID;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL GROWTH; CELL PROLIFERATION; CHRONIC LIVER DISEASE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; HEPATIC STELLATE CELL; IMMUNOPRECIPITATION; LIVER CELL; LIVER FIBROSIS; MALE; NONHUMAN; NORTHERN BLOTTING; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; SIGNAL TRANSDUCTION; AMINO ACID SEQUENCE; ANIMAL; CELL DIVISION; CHEMISTRY; DIMERIZATION; DRUG POTENTIATION; GENETICS; LIVER; LIVER CIRRHOSIS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; PATHOPHYSIOLOGY; WISTAR RAT;

AMINO ACID SEQUENCE; ANIMALS; ANTINEOPLASTIC AGENTS; BASE SEQUENCE; BENZOATES; CELL DIVISION; DIMERIZATION; EXTRACELLULAR MATRIX PROTEINS; FATTY ACIDS, UNSATURATED; GENE EXPRESSION; LIVER; LIVER CIRRHOSIS; MALE; MOLECULAR SEQUENCE DATA; PHENOTYPE; RATS; RATS, WISTAR; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; RETINOIDS; RNA, MESSENGER; TETRAHYDRONAPHTHALENES; TRANSCRIPTION FACTORS; TRETINOIN;

EID: 1442282022     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20015     Document Type: Article

References (58)

1. Geerts A. History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells. Semin Liver Dis 2001;21:311-335.
2. Marra F. Hepatic stellate cells and the regulation of liver inflammation. J Hepatol 1999;31:1120-1130.
3. Schuppan D, Ruehl M, Somasundaram R, Hahn EG. Matrix as a modulator of hepatic fibrogenesis. Semin Liver Dis 2001;21:351-372.
4. Ohata M, Lin M, Satre M, Tsukamoto H. Diminished retinoic acid signaling in hepatic stellate cells in cholestatic liver fibrosis. Am J Physiol 1997;272:G589-G596.
5. Friedman SL, Wei S, Blaner WS. Retinol release by activated rat hepatic lipocytes: regulation by Kupffer cell-conditioned medium and PDGF. Am J Physiol 1993;264:G947-G952.
6. De Luca LM. Retinoids and their receptors in differentiation, embryogenesis, and neoplasia. FASEB J 1991;5:2924-2933.
7. Idres N, Marill J, Flexor MA, Chabot GG. Activation of retinoic acid receptor-dependent transcription by all-trans-retinoic acid metabolites and isomers. J Biol Chem 2002;277:31491-31498.
8. Nagpal S, Chandraratna RAS. Recent developments in receptor-selective retinoids. Curr Pharm Des 2000;6:919-931.
9. Mader S, Leroy P, Chen JY, Chambon P. Multiple parameters control the selectivity of nuclear receptors for their response elements. Selectivity and promiscuity in response element recognition by retinoic acid receptors and retinoid X receptors. J Biol Chem 1993;268:591-600.
10. Davis BH, Kramer RT, Davidson NO. Retinoic acid modulates rat Ito cell proliferation, collagen, and transforming growth factor beta production. J Clin Invest 1990;86:2062-2070.
11. Pinzani M, Gentilini P, Abboud HE. Phenotypical modulation of liver fat-storing cells by retinoids. Influence on unstimulated and growth factor-induced cell proliferation. J Hepatol 1992;14:211-220.
12. Okuno M, Moriwaki H, Imai S, Muto Y, Kawada N, Suzuki J, Kojima S. retinoids exacerbate rat liver fibrosis by inducing the activation of latent TGFβ in liver stellate cells. HEPATOLOGY 1997;26:913-921.
13. Sato T, Kato R, Tyson CA. Regulation of differentiated phenotype of rat hepatic lipocytes by retinoids in primary culture. Exp Cell Res 1995;217:72-83.
14. Hellemans K, Grinko I, Rombouts K, Schuppan D, Geerts A. All-trans and 9-cis retinoic acid alter rat hepatic stellate cell phenotype differentially. Gut 1999;45:134-142.
15. Hoorens A, Van de Casteele M, Kloppel G, Pipeleers D. Glucose promote survival of rat pancreatic beta cell by activating synthesis of proteins which suppress a constitutive apoptotic program. J Clin Invest 1996;98:1568-1574.
16. Hellemans K, Michalik L, Dittié A, Knorr A, Rombouts K, De Jong J, Heirman C, et al. Peroxisome proliferator activated receptor beta contributes to enhanced hepatic stellate cell proliferation. Gastroenterology 2003; 124:184-201
17. Niki T, Schuppan D, De Bleser PJ, Vrijsen R, Pipeleers Marichal M, Beyaert R, Wisse E, et al. Dexamethasone alters mRNA levels but not synthesis of collagens, fibronectin, or laminin by cultured rat fat-storing cells. HEPATOLOGY 1996;23:1673-1681.
18. Leroy P, Krust A, Zelent A, Mendelsohn C, Garnier JM, Kastner P, Dierich A, et al. Multiple isoforms of the mouse retinoic acid receptor alpha are generated by alternative splicing and differential induction by retinoic acid. EMBO J 1991;10:59-69.
19. Nagpal S, Saunders M, Kastner P, Durand B, Nakshatri H, Chambon P. Promoter context- and response element-dependent specificity of the transcriptional activation and modulating functions of retinoic acid receptors Cell 1992;70:1007-1019.
20. Kastner P, Krust A, Mendelsohn C, Garnier JM, Zelent A, Leroy P, Staub A, et al. Murine isoforms of retinoic acid receptor gamma with specific patterns of expression. Proc Natl Acad Sci U S A 1990;87:2700-2704.
21. Brocard J, Kastner P, Chambon P. Two novel RXR alpha isoforms from mouse testis. Biochem Biophys Res Commun 1996;229:211-218.
22. Leid M, Kastner P, Lyons P, Nakshatri H, Saunders M, Zacharewski T, Chen JY, et al. Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell 1992;68:377-395.
23. Liu Q, Linney E. The mouse retinoid-X receptor-gamma gene: genomic organization and evidence for functional isoforms. Mol Endocrinol 1993; 7:651-658.
24. Bourguet W, Ruff M, Chambon P, Gronemeyer H, Moras D. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha. Nature 1995;375:377-382.
25. Rana B, Pearson AD, Redfern CP. RXR beta isoforms in neuroblastoma cells and evidence for a novel 3′-end transcript. FEBS Lett 2001;506:39-44.
26. Matsui T, Sashihara S. Tissue-specific distribution of a novel C-terminal truncation retinoic acid receptor mutant which acts as a negative repressor in a promoter- and cell-type-specific manner. Mol Cell Biol 1995;15:1961-1967.
27. Husmann M, Hoffmann B, Stump DG, Chytil F, Pfahl M. A retinoic acid response element from the rat CRBPI promoter is activated by an RAR/RXR heterodimer. Biochem Biophys Res Commun 1992;187:1558-1564.
28. Troen G, Nilsson A, Norum KR, Blomhoff R. Characterization of liver stellate cell retinyl ester storage. Biochem J 1994;300:793-798.
29. Davis BH, Rapp UR, Davidson NO. Retinoic acid and transforming growth factor beta differentially inhibit platelet-derived-growth-factor-induced Ito-cell activation. Biochem J 1991;278:43-47.
30. Davis BH, Vucic A. The effect of retinol on Ito cell proliferation in vitro. HEPATOLOGY 1988;8:788-793.
31. Chi X, Anselmi K, Watkins S, Gandhi CR. Prevention of cultured rat stellate cell transformation and endothelin-B receptor upregulation by retinoic acid. Br J Pharmacol 2003;139:765-774.
32. 4- or vitamin A-treated rats. Dig Dis Sci 1987;32:1281-1289.
33. Okuno M, Sato T, Kitamoto T, Imai S, Kawada N, Suzuki Y, Yoshimura H, et al. Increased 9,13-di-cis-retinoic acid in rat hepatic fibrosis: implication for a potential link between retinoid loss and TGFβ mediated fibrogenesis in vivo. J Hepatol 1999;30:1073-1080.
34. Koda H, Okuno M, Imai S, Moriwaki H, Muto Y, Kawada N, Kojima S. Retinoic acid-stimulated liver stellate cells suppress the production of albumin from parenchymal cells via TGF-beta. Biochem Biophys Res Commun 1996;221:565-569.
35. 4-treated rats. Gastroenterol Jpn 1990;25:223-229.
36. Imai S, Okuno M, Moriwaki H, Muto Y, Murakami K, Shudo K, Suzuki Y, et al. 9,13-di-cis-Retinoic acid induces the production of tPA and activation of latent TGFβ via RARα in a human liver stellate cell line, L190. FEBS Lett 1997;411:102-106.
37. Braunhut SJ, Moses MA. Retinoids modulate endothelial cell production of matrix-degrading proteases and tissue inhibitors of metalloproteinases (TIMP). J Biol Chem 1994;269:13472-13479.
38. Wan H, Dawson MI, Hong WK, Lotan R. Overexpressed activated retinoid X receptors can mediate growth inhibitory effects of retinoids in Human Carcinoma Cells. J Biol Chem 1998;273:26915-26922.
39. Kang JX, Li Y, Leaf A. Mannose-6-phosphate/insulin-like growth factor-11 receptor is a receptor for retinoic acid. Proc Natl Acad Sci U S A 1997;94:13671-13676.
40. Kang JX, Bell J, Beard RL, Chandraratna RAS. Mannose 6-phosphate/ insulin-like growth factor 11 receptor mediates the growth-inhibitory effects of retinoids. Cell Growth Differ 1999;10:591-600.
41. 4 intoxication in the rat. HEPATOLOGY 1996;23:1530-1537.
42. Klein ES, Pino ME, Johnson AT, Davies PJ, Nagpal S, Thacher SM, Krasinski G, et al. Identification and functional separation of retinoic acid receptor neutral antagonists and inverse agonists. J Biol Chem 1996;271:22692-22696.
43. Meisler NT, Parrelli J, Gendimenico GJ, Mezick JA, Cutroneo KR. All-trans retinoic acid inhibition of pro alpha1(I) collagen gene expression in fetal rat skin fibroblasts: identification of a retinoic acid response element in the pro alpha1(I) collagen gene. J Invest Dermatol 1997;108:476-481.
44. Wang L, Tankersley LR, Tang M, Potter JJ, Mezey E. Regulation of the murine alpha(2)(I) collagen promoter by retinoic acid and retinoid X receptors. Arch Biochem Biophys 2002;401:262-270.
45. Pan L, Eckhoff C, Brinckerhoff CE. Suppression of collagenase gene expression by all-trans and 9-cis retinoic acid is ligand dependent and requires both RARs and RXRs. J Cell Biochem 1995;57:575-589.
46. Suzuki C, Kayano K, Uchida K, Sakaida I, Okita K. Characteristics of the cell proliferation profile of activated rat hepatic stellate cells in vitro in contrast to their fibrogenesis activity. J Gastroenterol 2001;36:322-329.
47. Knittel T, Kobold D, Saile B, Grundmann A, Neubauer K, Piscaglia F, Ramadori G. Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibrogenic potential. Gastroenterology 1999;117:1205-1221.
48. DiRenzo J, Soderstrom M, Kurokawa R, Ogliastro MH, Ricote M, Ingrey S, Horlein A, et al. Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors. Mol Cell Biol 1997;17:2166-2176.
49. Boylan JF, Lufkin T, Achkar CC, Taneja R, Chambon P, Gudas LJ. Targeted disruption of retinoic acid receptor α (RARα) and RARγ results in receptor specific alterations in retinoic acid mediated differentiation and retinoic acid metabolism. Mol Cell Biol 2003;15:843-851.
50. Uchio K, Tuchweber B, Manabe N, Gabbiani G, Rosenbaum J, Desmouliere A. Cellular retinol-binding protein-1 expression and modulation during in vivo and in vitro myofibroblastic differentiation of rat hepatic stellate cells and portal fibroblasts. Lab Invest 2002;82:619-628.
51. Vollmar B, Siegmund S, Menger MD. An intravital fluorescence microscopic study of hepatic microvascular and cellular derangements in developing cirrhosis in rats. HEPATOLOGY 1998;27:1544-1553.
52. Vollmar B, Heckmann C, Richter S, Menger MD. High, but not low, dietary retinoids aggravate manifestation of rat liver fibrosis. J Gastroenterol Hepatol 2002;17:791-799.
53. Bosma A, Seifert WF, van Thiel-de Ruiter GC, van Leeuwen RE, Blauw B, Roholl P, Knook DL, et al. Alcohol in combination with malnutrition causes increased liver fibrosis in rats. J Hepatol 1994;21:394-402.
54. Senoo H, Wake K. Suppression of experimental hepatic fibrosis by administration of vitamin A. Lab Invest 1985;52:182-194.
55. Mizobuchi Y, Shimizu I, Yasuda M, Hori H, Shono M, Ito S. Retinyl palmitate reduces hepatic fibrosis in rats induced by dimethylnitrosamine or pig serum. J Hepatol 1998;29:933-943.
56. Geubel AP, De Galocsy C, Alves N, Rahier J, Dive C. Liver damage caused by therapeutic vitamin A administration: estimate of dose-related toxicity in 41 cases. Gastroenterology 1991;100:1701-1709.
57. Leo MA, Lieber CS. hepatic vitamin a depletion in alcoholic liver injury. N Engl J Med 1982;307:597-801.
58. Andreola F, Fernandez-Salguero PM, Chiantore MV, Petkovich MP, Gonzalez FJ, De Luca LM. Aryl hydrocarbon receptor knockout mice (AHR-/-) exhibit liver retinoid accumulation and reduced retinoic acid metabolism. Cancer Res 1997;57:2835-2838.